HomeRAPP • NASDAQ
add
Rapport Therapeutics Inc
Previous close
$14.81
Day range
$12.98 - $14.80
Year range
$12.98 - $29.74
Market cap
504.48M USD
Avg Volume
125.76K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 21.64M | 126.27% |
Net income | -17.54M | -101.37% |
Net profit margin | — | — |
Earnings per share | -0.50 | — |
EBITDA | -21.42M | -124.52% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 320.66M | — |
Total assets | 331.14M | — |
Total liabilities | 8.03M | — |
Total equity | 323.11M | — |
Shares outstanding | 36.58M | — |
Price to book | 1.68 | — |
Return on assets | -15.98% | — |
Return on capital | -16.31% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -17.54M | -101.37% |
Cash from operations | -16.42M | -202.64% |
Cash from investing | -53.04M | -101,901.92% |
Cash from financing | -1.39M | -101.63% |
Net change in cash | -70.85M | -188.69% |
Free cash flow | -12.03M | — |
About
Founded
2022
Headquarters
Website
Employees
58
